Step3 32 Flashcards
Psoriatic arthritis (5) and soft tissue and nails (4) characteristics
ARTHRITIS Asymmetric Olygoarthritis or Symmetric polyarthritis (similar to RA) Can include DIP joints Sacrilitis and spondilitis Arthritis multilans
NAILS AND SOFT TISSUE Dactylitis (sausage) Enthesitis Nail pitting/onycholysis Pitting edema of hand and feet
Serologic testing in Psoriatic arthritis
Negative rheumatoid factor and CCP
positive in 10%
Treatment of Psoriasis
Limited (10% skin involvement): topical steroids or vitamin D derivatives (calcipotriene)
Systemic treatment:
Methotrexate, cyclosporine, retinoids
Biologics
Management of nipple discharge
- Physical exam:
abnormal: imaging, biopsy, tests
normal: step 2 - US +/- mammogram (If >30yo)
abnormal: percutaneous biopsy
normal: Step 3 - Galactorrhea workup
abnormal: treat accordingly
normal: reassurance and observation
Patients super bothered by symptoms? consider duct extraction
X-ray findings of lead poisoning
Lead lines:
Opacification of metaphyseal plate
Treatment for lead poisoning
Chelation if lead >45
Succimer
Adetate calcium sodium (EDTA)
Manifestations of lead poisoning
Asymptomatic
Abdominal pain/constipation
Lead level as low as 10-20:
Cognitive impairment/behavioral problem (eg. ADHD)
Lead >70
Hemolytic anemia
Lead >100
Encephalopathy (AMS, seizures)
Diagnosis of multiple sclerosis
T2 MRI lesions disseminated in time and space: periventricular, juxtacortical, supratentorial, and spine
CSF:
oligoclonal IgG band
Usually reserved for patients with unclear diagnosis on MRI
Clinical features of MS
Onset 15-50 Optic neuritis Intranuclear ophthalmoplegia Motor symptoms (weakness) Sensory symptoms (paresthesias) Shooting pain down the spine Worsening symptoms in hot weather Bladder/bowel dysfuntion Fatigue Transverse myelitis (UMN symptoms)
Treatment of MS exacerbation
Steroids (oral equal to IV unless…)
IV prefered if patient has optic neuritis as oral medication can worsen the condition
Can taper to oral after IV
Plasmapheresis if no response to steroids
Treatment for MS
Exacerbation: steroids
Control: decrease frequency of exacerbations
B-interferon
Glatiramate acetate
MS and pregnancy
Clinical manifestations
Treatment
Delivery
Risk of child
Continue maintenance treatment unless the patient is being treated with teriflunomide and mitoxantrone are teratogenic
Usually less symptomatic during pregnancy and worse after postpartum
Increased risk of assisted delivery (vacuum. c-section)
Increased risk for child to have MS
Treatment for depression in MS
SSRI or SRNI
Treatment for urinary incontinence in MS
Schedule voiding
Fluid restriction
Anticholinergic medication:Doxybutinine, tolterodine (for urgency)
Treatment for spasticity in MS
Muscle stretching
Massage
Physical therapy
Muscle relaxants: Baclofen, tizanidine
Treatment for fatigue in MS
Sleep hygiene
Amantadine
Stimulants: methylphenidate, modafinil
Treatment for neuropathic pain MS
Gabapentin or duloxetine
Diagnosis of HCV infection
Antibody testing first:
Positive result:
Confirm with RNA test (NAT- nuclear acid test)
Positive result:
Treat with antiviral meds
Patients at risk for Influenza complications
> 65
Pregnant patient up to 2 weeks postpartum
Other comorbidities (diabetes, COPD, CAD)
Obesity
Immunocompromised
Nursing care facilities
Native Americans
CURB 65
Confusion Urea >30 Respiration >30 BUN: BP>90/60 >65
0-1: Outpatient
2: Ward
>3: ICU
Important clinical features of ADHD
> 6 months
In more than 2 settings (eg. school and home)
Symptoms appear before age 12
Treatment of ADHD
steps before medication and scalation
<6 years: parent-patient CBT
> 6 years or CBT failure:
Methylphenidate or amphetamine with prior cardiac exam and history. EKG if any hx or physical fidings
Atomoxetine
Alpha 2 adrenergic
If one stimulant fails (doesn’t work or too many side effects) after max dosing, switch to a different stimulant or a different medication
Titration of medication is done on a weekly basis. If no response after a couple of weeks.. switch